Skip to main content

Table 2 AIN-C midterm and final evaluation results

From: A retrospective review of the Honduras AIN-C program guided by a community health worker performance logic model

 

Baseline (1998)

Midterm (2000)

Final (2005)

Control (%)

AIN-C (%)

Control (%)

AIN-C (%)

No GMP (%)

AIN-C (%)

Child growth monitoring and promotion program awareness/participation

      

Caregivers know about the GMP program in their community

7

27

15

96a

100

Caregivers participate in the GMP program in their community

21

30

23

92a

Enrollment in GMP program within first month of life

27

28

24

Caregiver has a growth card for child with at least two weight measurements

64

59

68

91a

93

Attend weighing session 3 or more time in past 3 months

38

30

44

70a

67

Caregiver received counseling for child with at least one instance of growth faltering on their growth card

57

81a

81

Caregiver recognition of counseling cards

31

64a

45

73

KAP around growth and feeding

      

Exclusive breastfeeding of children under 6 months of age

15

21

13

39a

40

56b

Caregivers has their children 4 months of age or older take iron supplements

4

2

4

47a

30

66b

Caregiver aware that weight gain is sign of good growth

36

38

30

50a

33

51b

Caregiver aware that child being underweight is sign of poor growth

43

47

37

45a

41

48

KAP around illness

      

Child is fully immunized by the age of 12 months

65

62

66

76a

71

77

Gave oral rehydration therapy to child with diarrhea

36

37

42

57a

38

62b

Gave child fluids and continued feeding during a bout of diarrhea

17

21

16

33a

70

82b

Child experienced in episode of diarrhea in past 2 weeks taken to monitora or health care provider

25

34

41

47

Child who experience episode of ARI in past 2 weeks taken to monitora, pneumonia volunteer or health care provider

44

36

  1. Source [11, 15]
  2. aSignificant difference between AIN-C and control communities at midterm evaluation
  3. bSignificant difference between AIN-C and No GMP individuals at final evaluation